|
작성일 : 25-08-15 08:46
|
한게임바둑이추천 ∠ 54.rea731.top ∠ 바다이야기 프로그램
|
|
|
글쓴이 :
 조회 : 35
|
 http://2.rkc953.top [0] | | http://15.ren749.top [0] |
【15.rea731.top】
무료야마토릴게임골드몽야마토게임 다운로드오션파라다이스릴게임
사설배팅 ∠ 91.rea731.top ∠ 도그하우스 하는법
모바일 바다이야기 ∠ 70.rea731.top ∠ 야마토
프라그마틱 슬롯 하는법 ∠ 0.rea731.top ∠ 인터넷신천지
빠칭코게임 ∠ 0.rea731.top ∠ 신규슬롯사이트 스톰게임 황금성후기 파칭코사이트 바둑이넷마블 바다이야기 사이트 먹튀 야마토게임 하기 무료충전 바다이야기 파칭코 바다이야기게임다운 황금성게임사이트 릴게임놀이터 바다이야기다운로드 올벳매거진 강원랜드 잭팟 확률 릴게임총판 바다이야기먹튀신고 적토마게임 릴게임 체리마스터 파칭코 백경온라인 무료슬롯체험 골드몽 먹튀 현금게임 슬롯머신 프로그램 알라딘릴게임 사이트 오징어릴게임 메가슬롯 바다이야기먹튀신고 릴게임갓 슬롯버그 파칭코하는법 릴게임임대 Pg 소프트 무료 체험 릴게임황금성오션바다 10원야마토게임 릴게임신천지사이트 모바일릴게임 종류 무료황금성 황금성게임공략방법 오션파라다이스게임 오리자날 양귀비 릴게임안전사이트 최신바다이야기게임 체리마스터 황금성 사이트 오션파라다이스7하는곳 바다이야기 파일 바다이야기apk 마이크로 슬롯 무료체험 무료충전야마토 야마토게임 백경게임다운로드 바다이야기 pc버전 다운 릴게임갓 우주 전함 야마토 2205 손오공게임 야마토3게임다운로드 카지노 슬롯 게임 추천 체리마스터 어플 오락실게임 손오공 바다이야기5 온라인슬롯사이트 pc빠찡꼬게임 릴게임갓 체리마스터게임 야마토3동영상 알라딘 카카오릴게임 오션파라다이스 온라인 온라인야마토릴게임 슬롯사이트순위 바다이야기 기프트 전환 바다이야기 2화 온라인 슬롯 배팅법 오션파라다이스 게임 바다이야기 넥슨 오리지날야마토 릴게임갓 알라딘설명 슬롯 무료스핀 하이로우하는법 바다이야기 도박 모바일릴게임접속하기 릴게임사이다 사이다쿨 정글북 한게임바둑이 무료충전야마토 릴게임다운 중고게임기 매매 슬롯 머신 html 바다이야기규칙 야마토게임방법 야마토5게임다운로드 황금성게임종류 바다신게임 온라인 릴게임 성인오락황금성 알라딘다운로드 체리 마스터 pc 용 프라그마틱 슬롯 무료 바다이야기게임다운 알라딘먹튀 황금성게임후기 릴게임팡게임 프라그마틱 무료체험 메타 릴게임 5만 빠징코 슬롯머신 인터넷빠찡꼬 오션파라다이스 다운로드 온라인삼국지 올쌈바 강원랜드슬롯머신 백경예시 황금성릴 야마토5게임방법 바다이야기게임 슬롯총판 온라인 야마토 게임 슬롯 무료 사이트 스위피릴게임 손오공 릴게임 야마토게임 파칭코슬롯 [Shin-Min Joon, Edaily Reporter] Huons has achieved record quarterly results for the second quarter.
Huons CI. (Image=Huons)
Huons today announced its preliminary earnings for the second quarter of this year, reporting consolidated sales of 156 billion won , operating profit of 13.1 billion won , and net pr 한국장학재단 학자금대출 ofit of 11.8 billion won , reflecting year-on-year increase of 4.7%, 40.3%, and 46.5%, respectively.
Quarterly sales surpassed 150 billion won , setting a new record for the highe 이스타항공 st quarterly revenue. Operating profit also saw a significant increase compared to the same period last year, continuing the trend of improved profitability following the first quarter.
Huon 신한은행 신용등급무료조회 s showed balanced growth across all business segments in the second quarter, with improved performances from subsidiaries. Both Huons N, a subsidiary specializing in health functional foods that compl 신한카드 자동차할부 eted its spin-off and merger in May, and HuonsLifeSciences, specialized in ethical drug (ETC), successfully turned to profit. Additionally, Pangen Biotech, acquired late last year, was included as Huo 새희망홀씨상환기간 ns’ consolidated subsidiary starting this June.
By business segment, the ETC division recorded sales of 69.1 billion won in the second quarter. The division continued its stable growth, led by its metabolic disease drugs and injectable exports, marking a 3.9% increase year-on-year. Notably, injectable exports to North America in the second quarter reached 5.4 billion won , a 51% surge compared to the same period last year.
Sales from the beauty and wellness segment recorded 42.2 billion won , a 13.3% decrease year-on-year. This was due to the transfer of the health functional food business unit’s performance to Huons N, starting last May. Excluding the health functional food business, beauty and wellness sales grew by 7.7% to 37 billion won , driven by strong sales of the continuous glucose monitor system, Dexcom G7.
Huons‘ R&D expenses in Q2 amounted to won 9.8 billion, up 9.8% YOY. Sales from the Contract Manufacturing Organization (CMO) business increased by 7.4% to 20.8 billion won . This growth was driven by a rise in both contract manufacturing for eye drops, following the operation of the new eye drop line at Plant 2, and other pharmaceutical contract services.
In May Huons received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its products, 1% and 2% multiple-dose vials for lidocaine hydrochloride injection. Huons plans to expand its export portfolio to the U.S. by pursuing new registration for its dental anesthetics.
Huons aims to achieve both sales growth and improved profitability in the second half of the year, with the new injectable product line at Plant 2 scheduled for operation in the third quarter. Additionally its health functional food subsidiary Huons N also saw a 76.7% growth in second quarter sales recording 18.7 billion won .
Huons CEO Song Soo young said, “This record high quarterly performance was driven by the stable growth of its existing businesses and the strong performance of its subsidiaries. With the successful spin off and merger of health functional food business unit and the full scale operation of a new production facility in the second half of the year, we expect to secure both sustained top-line growth and profitability.”
On the same day the board of directors approved a cash dividend of 150 won per share and set the record date for the dividend as August 21, in accordance with the revised Financial Investment Services and Capital Markets Act. The record date, which was previously June 30 was changed to the date after the dividend was announced.
The per share dividend for this interim period has slightly decreased compared to the previous year. Although the dividend per share was determined in consideration of the rapidly changing business environment the company plans to maintain its existing policy of increasing the total annual dividend including the year end dividend by 0% to 30% compared to the previous year.
The capital reserve reduction and reduced dividends approved at this year’s AGM do not apply to the interim dividend but will take effect from the year-end dividend. If the year end payout increases, shareholders are expected to benefit from greater tax exempt dividends.
신민준 (adonis@edaily.co.kr)
|
|
|
